Trial intelligence / Profile preview

ASAQ vs Chloroquine in Uncomplicated P. Vivax Malaria

NCT01378286Phase 3Completed

Sponsor
Sanofi
Start
Jan 2012
Primary completion
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of artesunate + amodiaquine in malaria, sponsored by Sanofi. Started Jan 2012; status: completed.

02

Drugs

artesunate + amodiaquine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT01378286.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01378286.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call